Medicare Enrolled

Dr. Laertes Manuelidis, M.D.

Dermatopathology (Pathology) Physician · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8381 RIVERWALK PARK BLVD, Fort Myers, FL 33919
2399365425
In practice since 2005 (20 years)
NPI: 1245220698 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manuelidis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manuelidis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manuelidis

Dr. Laertes Manuelidis is a dermatopathology (pathology) physician in Fort Myers, FL, with 20 years in practice. Based on federal Medicare data, Dr. Manuelidis performed 29,048 Medicare services across 9,054 unique beneficiaries.

Between the years covered by Open Payments, Dr. Manuelidis received a total of $182,006 from 11 pharmaceutical and/or device companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology (pathology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manuelidis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 20% volume in FL$ $182,006 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,048
Medicare services
Top 20% in FL for dermatopathology (pathology) physician
9,054
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,452 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, tildrakizumab, 1 mg12,500$110$220
Office visit, established patient (20-29 min)2,948$63$189
Destruction of precancerous skin growths, 2-142,895$5$13
Tissue pathology examination, moderate complexity2,860$56$144
Destruction of precancerous skin growth, 11,503$35$138
Artacent ac, per square centimeter1,042$398$935
Artacent wound, per square centimeter460$318$627
Destruction of skin growths (warts/lesions), 1-14393$64$235
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm312$75$259
Destruction of precancer skin growth, 15 or more growths284$130$349
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm280$90$293
Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less244$109$310
Skin biopsy, tangential213$62$214
Office visit, established patient (10-19 min)212$43$117
Drug injection, under skin or into muscle174$10$32
Tissue staining for diagnosis, initial162$80$214
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm153$86$292
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm147$121$377
Tissue staining for diagnosis, additional147$68$188
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm146$115$374
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm132$92$310
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm116$75$260
New patient office visit (30-44 min)99$71$236
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm88$155$517
Biopsy of ear85$56$205
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm78$160$593
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm74$149$433
Treatment of inflammatory skin disease using laser, less than 250.0 sq cm72$125$327
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)64$306$627
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm62$135$568
Pathology examination of tissue using a microscope, moderately low complexity60$34$86
Biopsy of eyelid59$130$389
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm58$109$333
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm54$115$349
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm53$89$299
Special stained specimen slides to identify organisms including interpretation and report52$89$228
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm51$386$1,004
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm50$133$396
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less47$70$247
Destruction of skin growth, 15 or more growths45$84$277
Punch biopsy, first skin growth43$90$270
Application of light to destroy precancer skin growth43$107$292
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm42$334$908
Biopsy of related skin growth, each additional growth39$41$109
Steroid injection (triamcinolone)38$1$6
Biopsy of lip37$68$261
Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm36$133$357
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm35$226$643
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm32$162$535
Injection into skin growth, more than 7 growths27$41$148
Shaving of skin growth of body, arms, or legs, more than 2.0 cm22$99$324
Complicated repair of wound of trunk, 2.6-7.5 cm21$302$844
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm21$130$405
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less20$82$295
Shaving of skin growth of body, arms, or legs, 0.5 cm or less17$63$213
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm17$71$363
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm17$159$440
Simple or single drainage of skin abscess15$99$261
Punch biopsy, each additional skin growth14$49$127
Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm14$375$1,047
Injection into skin growth, 1-7 growths13$32$118
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm11$189$633
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$182,006
Total received (2018-2024)
Avg $26,001/year across 7 years
Top 3% in FL for dermatopathology (pathology) physician
11
Companies
199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138,039 (75.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,067 (23.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$900 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,241
2023
$42,297
2022
$27,480
2021
$70,217
2020
$12,655
2019
$88
2018
$27

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$99,005
Sun Pharmaceutical Industries Inc.
$80,834
UCB, Inc.
$1,422
Janssen Biotech, Inc.
$316
ABBVIE INC.
$197
Lilly USA, LLC
$103
PFIZER INC.
$48
Celgene Corporation
$27
Regeneron Healthcare Solutions, Inc.
$21
Galderma Laboratories, L.P.
$17
Incyte Corporation
$15
Top 3 companies account for 99.6% of total payments
Associated products mentioned in payments ›
Absorica LD · BLU-U · Bimzelx · CIBINQO · Cimzia · DUPIXENT · EUCRISA · ILUMYA · Ilumya · OPZELURA · Otezla · REMICADE · RINVOQ · SKYRIZI · TALTZ · TREMFYA · Winlevi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatopathology (pathology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for dermatopathology (pathology) physician in FL.

Equivalent to $627 per 100 Medicare services performed
Looking for a dermatopathology (pathology) physician in Fort Myers?
Compare dermatopathology (pathology) physicians in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse dermatopathology (pathology) physicians nearby

Geographic Context

Dermatopathology (Pathology) Physicians within 10 mi
1
Per 100K population
0.1
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
4.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Manuelidis is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Manuelidis experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Manuelidis performed 12,500 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manuelidis receive payments from pharmaceutical companies?
Yes. Dr. Manuelidis received a total of $182,006 from 11 companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manuelidis's costs compare to other dermatopathology (pathology) physicians in Fort Myers?
Dr. Manuelidis's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manuelidis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →